Aethlon Medical Inc.
13F holders, Q2 2024 (June 30)18holders +8
8new positions
0sold out
$0.49avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Aethlon Medical Inc. in their 13F filings, up 8 from Q1 2024. 8 opened new positions and 0 sold out. The largest holders were Susquehanna International Group, LLP ($18K), Two Sigma Securities, LLC ($17K) and Jane Street Group, LLC ($13K).
- Company
- Aethlon Medical Inc.
- CUSIP
- 00808Y406
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $60K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 129,455 shares bought and 119 shares sold, net +129,336 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Susquehanna International Group, LLP | 0.00% | New | 36,652 | $18K |
| Two Sigma Securities, LLC | 0.00% | New | 34,544 | $17K |
| Jane Street Group, LLC | 0.00% | New | 26,408 | $13K |
| Vanguard Group Inc. | 0.00% | No change | 21,224 | $11K |
| Geode Capital Management, LLC | 0.00% | No change | 20,274 | $10K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 13,251 | $5K |
| HRT Financial LP | 0.00% | New | 10,088 | $5K |
| BlackRock Inc. | 0.00% | No change | 7,340 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +506.2% | 6,892 | $3K |
| UBS Group AG | 0.00% | Add +1191.0% | 1,730 | $863 |
| Group One Trading LLC | 0.00% | No change | 1,217 | $607 |
| Qube Research & Technologies Ltd | 0.00% | New | 1,100 | $549 |
| Wells Fargo & Company | 0.00% | Reduce -8.3% | 211 | $105 |
| Osaic Holdings, Inc. | 0.00% | Reduce -33.4% | 199 | $99 |
| Morgan Stanley | 0.00% | No change | 89 | $44 |
| Anfield Capital Management, LLC | 0.00% | New | 41 | $20 |
| Bartlett & Co. Wealth Management LLC | 0.00% | No change | 26 | $13 |
| Bank of America Corp. | 0.00% | New | 20 | $10 |
"% of holder's portfolio" is AETHLON MEDICAL INC's weight in each manager's 13F, not the share of Aethlon Medical Inc. the manager owns.